دورية أكاديمية

P1141: IBRUTINIB AND RITUXIMAB AS FIRST LINE THERAPY FOR MANTLE CELL LYMPHOMA: A MULTICENTRE, REAL-WORLD UK STUDY

التفاصيل البيبلوغرافية
العنوان: P1141: IBRUTINIB AND RITUXIMAB AS FIRST LINE THERAPY FOR MANTLE CELL LYMPHOMA: A MULTICENTRE, REAL-WORLD UK STUDY
المؤلفون: Tivey, A., Shotton, R., Eyre, T. A., Lewis, D., Crosbie, N., Nga, E., Guerrero Camacho, R., Swe, W., Marr, H., Rees, C., Moule, S., Sutton, T., Wrench, D., Thomas, N., Wilson, M., Bailey, J., Prahladan, M., Hodson, A., Koppana, M., Smith, S., Jones, S., Miall, F., Norman, J., Davies, E., Hildyard, C., Lowry, L., Paneesha, S., Qureshi, I., Beech, A., Bedford, C., Everden, A., Tucker, D., Wright, J., Goddard, J., Nicholson, T., Wilson, J., Lord, A., Jackson, B., Flont, M., Gibb, A., Linton, K.
المصدر: HemaSphere ; volume 6, page 1031-1032 ; ISSN 2572-9241
بيانات النشر: Wiley
سنة النشر: 2022
المجموعة: Wiley Online Library (Open Access Articles via Crossref)
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1097/01.hs9.0000847432.95668.eb
DOI: 10.1097/01.HS9.0000847432.95668.eb
الإتاحة: https://doi.org/10.1097/01.hs9.0000847432.95668.ebTest
حقوق: http://creativecommons.org/licenses/by-nc-nd/4.0Test/
رقم الانضمام: edsbas.F458320
قاعدة البيانات: BASE